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Effect of local glial derived neurotrophic factor (GDNF) on nerve regeneration was assessed. Eighty male
Wistar rats were divided into four experimental groups (n ¼ 20), randomly: In transected group left
sciatic nerve was transected and stumps were ﬁxed in adjacent muscle. In treatment group defect was
bridged using an artery graft ﬁlled with 10 mL GDNF. In artery group graft was ﬁlled with phosphate-
buffered saline. In normal control group sciatic nerve was exposed and manipulated. Each group was
subdivided into four subgroups of ﬁve animals each and nerve ﬁbers were studied in a 16-week period.
Behavioral, functional, electrophysiological and gastrocnemius muscle mass ﬁndings and morphometric
indices conﬁrmed faster recovery of regenerated axons in IOAG/GDNF than in IOAG group (p < 0.05).
Immunohistochemical reactions to S-100 in IOAG/GDNF were more positive than that in IOAG group.
GDNF improved functional recovery and morphometric indices of sciatic nerve. It could be considered as
an effective treatment for peripheral nerve repair in practice.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Despite variability and unpredictability of functional outcome
after nerve repair, technological advances in diagnostic imaging,
neurosurgical instrumentation and the use of a surgical microscope
have resulted in pronounced improvements in the diagnosis and
repair of transected peripheral nerves [1]. Nerve autograft remains
the gold standard, however, there are several drawbacks such as
sacriﬁce of functioning nerves, loss of sensation and mismatch
between nerve and graft [2]. The ideal surgical repair technique
should accomplish good wound healing with minimal scar forma-
tion and direct the nerve sprouts into their correct targets [3]. The
conduits act to guide axons sprouting from the regenerating nerve
end, provide a microenvironment for diffusion of neurotrophic and
neurotropic factors secreted by the injured nerve stump, as well as
help protect from inﬁltration of ﬁbrous tissue [4]. An artery graft
presents large quantities of laminin and some collagen. These, r.mohammadi@urmia.ac.ir
by Elsevier Ltd. All rights reservedsubstances are also found in Schwann-cell basal membrane and are
reported as axonal outgrowth factors [5,6]. Laminin, one of the
main basal membrane components, stimulates neurite outgrowth,
induces Schwann-cell mitosis, and plays a fundamental role in
peripheral nerve regeneration [7,8]. As well as requiring nerve ﬁber
contact, normal Schwann-cell differentiation requires contact with
a connective tissue matrix or some associated material such as
collagen [9]. Standard artery graft basal membrane tube diameter is
large, and the contact surface for migrating Schwann cell or axonal
outgrowth cone adhesion becomes very small [10]. Nevertheless, in
inside-out artery grafts, this negative effect might be diminished
once the adventitia provides a permissive matrix which increases
the contact surface for axons [11].
Neurotrophic factors have been extensively investigated in an-
imal models of nerve injury to further enhance and accelerate the
process of nerve regeneration and functional recovery [12]. Neuro-
trophic factors support the survival of axotomized neurons and
enhance the intrinsic regenerative capacity after retrograde uptake
and induction of speciﬁc signaling cascades. One member of the
transforming growth factor superfamily, glial cell line-derived
neurotrophic factor (GDNF), has been shown to promote the sur-
vival and function of several neuronal populations in the peripheral.
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survival of neurons in culture and in vivo after peripheral nerve
injury. GDNF is a potent motoneuron factor which prevents
motoneuron degeneration in mice and rats after axotomy [15,16].
Aimed to study local effects of GDNF on peripheral nerve
regeneration, a study was designed to determine if local GDNF
could in fact reduce dysfunction after nerve injury in the rat sciatic
nerve transectionmodel. Assessment of the nerve regenerationwas
based on behavioral, functional, histomorphometric and immuo-
histochemical (Schwann cell detection by S-100 expression) criteria
4, 8, 12 and 16 weeks after surgery.2. Materials and methods
2.1. Study design and animals
Eighty male Wistar rats weighing approximately 290 g were
divided into four experimental groups (n ¼ 20), randomly: normal
control group as normal control (NC), transected control (TC), in-
side-eout artery graft (IOAG) and GDNF treated group (IOAG/
GDNF). Twenty rats were used as artery graft donors. Each group
was further subdivided into four subgroups of ﬁve animals each
and surveyed 4, 8, 12 and 16 weeks after surgery. Twoweeks before
and during the experiments, the animals were housed in individual
plastic cages with an ambient temperature of (23  3) C, stable air
humidity and a natural day/night cycle. The rats had free access to
standard rodent laboratory food and tap water. All measurements
were made by two blinded observers unaware of the analyzed
groups.2.2. Surgical procedure
Animals were anesthetized by intraperitoneal administration of
ketamine-xylazine (ketamine 5%, 90 mg/kg and xylazine 2%, 5 mg/
kg). The procedure was carried out based on the guidelines of the
Ethics Committee of the International Association for the Study of
Pain [17]. The University Research Council approved all
experiments.
Following surgical preparation in the normal control group, the
left sciatic nervewas exposed through a gluteal muscle incision and
after careful homeostasis the muscle was sutured with resorbable
4/0 sutures, and the skinwith 3/0 nylon. In TC group, the left sciatic
nerve was transected proximal to the tibio-peroneal bifurcation
where a 7 mm segment was excised, leaving a 10 mm gap due to
retraction of nerve ends. Proximal and distal stumps were ﬁxed in
the adjacentmuscle with 10/0 nylon epineurial suture. No graft was
interposed between the stumps. In the IOAG group, a 7-mm nerve
segment was resected to produce a 10 mm nerve gap after retrac-
tion of the nerve transected ends. The gap was bridged using an
artery graft, entubulating 2mmof the nerve stump at each end. The
artery graft was harvested from abdominal aorta of donor animals.
The abdominal aorta artery was exposed through a midline
abdominal incision and cannulated. Then, a 15 mm segment was
harvested on the cannula. Donor animals were sacriﬁced after graft
harvest using a high-dose anesthetic. Harvested grafts were
washed in physiological solution and left at room temperature for
40 min. A subtle retraction of 1 mm was already expected. Each
graft was inverted inside-out by pulling it down the cannula with
microsurgery tweezers. Allografts did not receive preliminary
treatment to reduce their antigenicity. Two 10/0 nylon sutures were
used to anchor the graft to the epineurium at each end. In GDNF
treated group (IOAG/GDNF) the graft was ﬁlled with 10 ml GDNF
(100 ng/kg). The animals were anesthetized and euthanized with
transcardiac perfusion of a ﬁxative containing 2%paraformaldehyde and 1% glutaraldehyde buffer (pH 7.4) 4, 8, 12
and 16 weeks after surgery.
2.3. Behavioral testing
Functional recovery of the nerve was assessed using the Basso,
Beattie, and Bresnahan (BBB) locomotor rating scale for rat hind
limb motor function [18]. Although BBB is widely used to assess
functional recovery in spinal cord injured animals, however, it has
been demonstrated that it could be most useful in assessment of
never repair processes in peripheral nerve injuries [19]. Scores of
0 and 21 were given when there were no spontaneous movement
and normal movement, respectively. A score of 14 shows full
weight support and complete limbs coordination. BBB recordings
were performed by a trained observer who was blinded to the
experimental design. The testing was performed in a serene envi-
ronment. The animals were observed and assessed within a course
of a 4-min exposure to an open area of a mental circular enclosure.
BBB scores were recorded once before surgery in order to establish
a baseline control and again weekly thereafter to assess functional
recovery during 16 weeks.
3. Functional assessment of reinnervation
3.1. Sciatic functional index (SFI)
Walking track analysis was performed 4, 8 12 and 16weeks after
surgery based on themethod of others [20]. The lengths of the third
toe to its heel (PL), the ﬁrst to the ﬁfth toe (TS), and the second toe
to the fourth toe (IT) were measured on the experimental side (E)
and the contralateral normal side (N) in each rat. The sciatic func-
tion index (SFI) of each animal was calculated by the following
formula:
SFI ¼ 38:3 ðEPL NPLÞ=NPL þ 109:5 ðETSNTSÞ=NTS
þ 13:3 ðEITNITÞ=NIT 8:8
In general, SFI oscillates around 0 for normal nerve function,
whereas around 100 SFI represents total dysfunction. SFI was
assessed in the NC group and the normal level was considered as 0.
SFI was a negative value and a higher SFI meant the better function
of the sciatic nerve.
3.2. Static sciatic index (SSI)
SSI is a time-saving digitized static footprint analysis described
by others [21]. A good correlation between the traditional SFI and
the newly developed static sciatic index (SSI) and static toe spread
factor (TSF), respectively, has been reported by others [21]. The SSI
is a time-saving and easy technique for accurate functional
assessment of peripheral nerve regeneration in rats and is calcu-
lated using the static factors, not considering the print length factor
(PL), according to the equation:
SSI ¼ ½ð108:44 TSFÞ þ ð31:85 ITSFÞ  5:49
Where:
TSF ¼ ðETS NTSÞ=NTS
ITSF ¼ ðEIT NITÞ=NIT
Like SFI, an index score of 0 was considered normal and an index
of 100 indicated total impairment. When no footprints were
measurable, the index score of 100 was given.
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At the end of the study period, following walking track, all an-
imals were subjected to electrophysiological studies using Nacro
bio system 320-3760 A trace 80 (USA). Under general anesthesia,
the left sciatic nerve was re-exposed by incision of the skin at the
previous surgical site. Single electrical pulses at supramaximal in-
tensity were delivered via bipolar electrodes placed in turn at the
proximal and distal trunk of the grafted nerve and EMG was
recorded by inserting an electrode into the belly of gastronemius
muscle.
The difference in latency of EMG was measured, and the dis-
tance between the proximal and distal sites of stimulation was
measured to calculate the conduction velocity across the regener-
ated tissue cable. On the contralateral side of each animal similar
measurement was made for determination of conduction velocity.
The conduction velocity of the bridged nerve was expressed as a
percentage of that on the intact side of each animal to cancel off
variations between animals (% CVR) [22].3.4. Muscle mass
Recovery assessment was also indexed using the weight ratio of
the gastrocnemius muscles 16 weeks after surgery. Immediately
after sacriﬁcing of animals, gastrocnemius muscles were dissected
and harvested carefully from intact and injured sides and weighed
while still wet, using an electronic balance.3.5. Histological preparation and morphometric studies
Nerve mid-substance in IOAG group, nerve mid-substance in
IOAG/GDNF treated group, midpoint of normal sciatic nerve (NC)
and regenerated mid substance of TC group were harvested and
ﬁxed with glutaraldehyde 2.5%. They were post ﬁxed in OsO4 (2%,
2 h), dehydrated through an ethanol series and embedded in
parafﬁn. The nerves were cut in 5 mm in the middle, stained with
toluidine blue and examined under light microscopy. Morpho-
metric analysis was carried out using an image analyzing software
(Image-Pro Express, version 6.0.0.319, Media Cybernetics, Silver
Springs, MD, USA). Equal opportunity, systematic random sampling
and two-dimensional dissector rules were followed in order to
cope with sampling-related, ﬁber-location-related and ﬁber-size
related biases [23].Fig. 1. BBB score for all experimental groups. Topical administration of GDNF I with
artery grafting gave better scores than in IOAG group. Standard error at each data point
is shown with bars.3.6. Immunohistochemical analysis
In this study, anti-S-100 (1:200, DAKO, USA) was used as marker
for myelin sheath. Specimens were post ﬁxed with 4% para-
formaldehyde for 2 h and embedded in parafﬁn. Prior to immu-
nohistochemistry nerve sections were dewaxed and rehydrated in
PBS (pH 7.4). Then the nerve sections were incubated with 0.6%
hydrogen peroxide for 30 min. To block non-speciﬁc immuno-
reactions the sections were incubated with normal swine serum
(1:50, DAKO, USA). Sections were then incubated in S-100 protein
antibody solution for 1 h at room temperature. They were washed
three times with PBS and incubated in biotynilated anti-mouse
rabbit IgG solution for 1 h. Horseradish peroxidase-labeled sec-
ondary antibody was applied for 1 h. After that all sections were
incubated with 3,30-diaminobenzidine tetrahydrochloride chro-
mogene substrate solution (DAB, DAKO, USA) for 10 min. The re-
sults of immunohistochemistry were examined under a light
microscope.3.7. Statistical analysis
The results were expressed as means  SD. Statistical analyses
were performed using PASW 18.0 (SPSS Inc., Chicago, IL, USA).
Model assumptions were evaluated by examining the residual plot.
Results were analyzed using a factorial ANOVA with two between-
subjects factors. Bonferroni test for pairwise comparisons was used
to examine the effect of time and treatments. The differences were




In order to assess hind limb recovery the open ﬁeld locomotor
was used. Fig. 1 shows BBB scores compared to the baseline. All
experimental groups, except for NC, showed the greatest degree of
functional deﬁcit one week after surgery. The GDNF treated group
showed signiﬁcant improvement in locomotion of the operated
limb compared to the IOAG group during the study period
(P < 0.05).
4.2. Recovery of sciatic nerve function
4.2.1. SFI outcome
Fig. 2 shows sciatic function index (SFI) values in all four
experimental groups. Prior to surgery, SFI values in all groups were
near zero. After the nerve transection, the mean SFI decreased
to 100 due to the complete loss of sciatic nerve function in all
animals. At the end of the study period, animals of GDNF group
achieved a mean value for SFI of 31.2  4.19 whereas in group
IOAG a mean value of 52.3  4.12 was found. The statistical
analyses revealed that the recovery of nerve function was signiﬁ-
cantly (P < 0.05) different between IOAG/GDNF and IOAG groups
and application of the GDNF in artery graft signiﬁcantly accelerated
functional recovery in the course of time.
4.2.2. SSI outcome
Changes in SSI were similar to those observed in SFI, indicating
signiﬁcant deﬁcit following the sciatic nerve transection (Fig. 3).
Changes in SSI were signiﬁcant at weeks 4, 8, 12 and 16 of recovery
(P < 0.05). The contrasts indicate SSI values in group IOAG/GDNF at
week 16 to differ signiﬁcantly from those obtained from IOAG, a
trend also noticed for SFI (P < 0.05).
Fig. 2. Box-and-whisker plots of sciatic nerve function index values in each experi-
mental group during the study period. Topical administration of GDNF I with artery
grafting gave better results in functional recovery of the sciatic nerve than in IOAG
group.
Fig. 3. Bar graph indicating static sciatic index (SSI) values in each experimental group
during the study period. Topical administration of GDNF I with inside-out artery
grafting gave better results in functional recovery of the sciatic nerve than in IOAG
group. Data are presented as mean  SD. *P < 0.05 vs IOAG group.
Fig. 4. Percentage recovery of conduction velocity in experimental groups. Data are
presented as mean  SD. *P < 0.005 vs IOAG group.
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Fig. 4 shows nerve conduction velocity (NCV) along regenerated
sciatic nerves in experimental groups. NCV in GDNF treated animals
was signiﬁcantly higher than that in IOAG group (P < 0.05).
4.2.4. Muscle mass measurement
The mean ratios of gastrocnemius muscle weight were
measured at the end of the study period. There was a statistically
signiﬁcant difference between the muscle weight ratios of the
IOAG/GDNF and IOAG groups (P < 0.05). The results showed that in
the GDNF treated group, the muscle weight ratio was larger than in
the IOAG group, and weight loss in the gastrocnemius muscle was
ameliorated by GDNF local administration (Fig. 5).
4.2.5. Histological and morphometric ﬁndings
The GDNF treated group presented signiﬁcantly greater nerve
ﬁber, axon diameter, and myelin sheath thickness during study
period, compared to IOAG animals (P< 0.05). Normal control group
presented signiﬁcantly greater nerve ﬁber and axon diameter, and
myelin sheath thickness compared to IOAG/GDNF and IOAG groups
animals (Figs. 6e9). In case of myelin thickness there was nosigniﬁcant difference between IOAG/GDNF and IOAG groups,
morphometrically (P > 0.05).4.2.6. Immunohistochemistry
Immunoreactivity to S-100 protein was extensively observed in
the cross sections of regenerated nerve segments. The expression of
S-100 protein signal was located mainly in the myelin sheath. The
axon also showed a weak expression indicating that Schwann cell-
like phenotype existed around the myelinated axons (Fig. 10). In
both IOAG/GDNF and IOAG groups, the expression of S-100 and the
ﬁndings resembled those of the histological evaluations.5. Discussion
It is known from previous studies that regeneration process in
rats would not have been completed by 12 weeks, a phenomenon
which has been reported in a variety of experimental models [24].
Quantitatively, our results are consistent with these ﬁndings.
However, a 12-week experimental period is sufﬁcient for evalua-
tion of regeneration process because in rats functional recovery
after repair of a transected peripheral nerve occurs during this
timeline [25].
The results of the present study showed that application of
GDNF in an artery graft resulted in faster functional recovery of the
sciatic nerve during the study period. Left gastrocnemius muscle
weight was signiﬁcantly greater in the IOAG/GDNF group than in
the IOAG group, indicating indirect evidence of successful end or-
gan reinnervation in the GDNF treated animals. It has been
demonstrated that morphometric indices are measures of regen-
erated nerve maturity and quality of regeneration [26,27]. Larger
diameters of axons and thicker myelination give rise to improved
nerve function compared to smaller and thinner myelinated ﬁbers
[28]. Loading of GDNF into IOAG conduit at the nerve repair site
increased ﬁber maturity.
At week 16 quantitative morphometrical indices of regenerated
nerve ﬁbers showed signiﬁcant differences between the IOAG and
IOAG/GDNF groups, indicating a beneﬁcial effect of local application
of GDNF on the nerve regeneration.
Although both morphological and functional data have been
used to assess neural regeneration after induced crush injuries, the
correlation between these two types of assessment is usually poor
[29e31]. Classical and newly developedmethods of assessing nerve
recovery, including histomorphometry, retrograde transport of
horseradish peroxidase and retrograde ﬂuorescent labeling [32] do
not necessarily predict the reestablishment of motor and sensory
Fig. 5. Gastrocnemius muscle weight measurement. The gastrocnemius muscles of
both sides (operated left and unoperated right) were excised and weighed in the
experimental groups at 16 weeks after surgery. Data are presented as mean  SD.
*P < 0.05 vs IOAG group.
Fig. 6. The graph shows the quantitative results of ﬁber counting. The mean number of
nerve ﬁbers in NC group was nearly 8326  211 (mean  SD). Both groups of IOAG and
IOAG/GDNF showed the lower number of ﬁbers than the NC group even at the end of
the study period.
Fig. 8. The graph shows the quantitative results of mean diameter of axons. The mean
diameter of axons in NC group was nearly 7.3  0.09 (mean  SD). Both groups of IOAG
and IOAG/GDNF showed the lower mean diameter of axons than the NC group even at
the end of the study period.
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studying the nerve regeneration process, they generally fail in
assessing functional recovery [30]. Therefore, research on periph-
eral nerve injury needs to combine both functional andFig. 7. The graph shows the quantitative results of mean diameter of nerves ﬁbers. The
mean diameter of nerve ﬁbers in NC group was nearly 12.6  0.11 (mean  SD). Both
groups of IOAG and IOAG/GDNF showed the lower mean diameter of nerve ﬁbers than
the NC group even at the end of the study.morphological assessment. Castaneda et al., [25] suggested that
arrival of sprouts from the proximal stump at the distal nerve
stump does not necessarily imply recovery of nerve function. In-
formation taken from BBB scale may be invaluable in evaluation of
peripheral nerve process. Results of the present study showed that
the GDNF treated animals had been improved in locomotion of the
operated limb compared to the IOAG group during the study
period. Walking track analysis has frequently been used to reliably
determine functional recovery following nerve repair in rat models
[21,34]. Nerve conduction measurement is a direct evidence for the
study of nerve transmission [36]. The conduction velocity depends
on the diameter of axons and the thickness of myelin sheath [37].
The results of the present study showed signiﬁcantly different
conduction velocity between the GDNF treated animals and IOAG
bridged regenerated sciatic nerves, therefore, the IOAG conduit in
combination with GDNF could be assumed as a safe nerve guide
with no nerve conduction interference. To achievemaximal efﬁcacy
in nerve transection models doseeresponse studies remain to be
conducted for GDNF to determine the combination of the graft and
the compound.
Several nerve guidance conduits (NGCs) and nerve protectant
wraps are approved by the US Food and Drug Administration (FDA)Fig. 9. The graph shows the quantitative results of mean thickness of myelin sheath.
The mean thickness of myelin sheath in NC group was nearly 2.4  0.04 (mean  SD).
Both groups of IOAG and IOAG/GDNF showed the lower mean diameter of axons than
the NC group even at the end of the study period.
Fig. 10. Immunohistochemical analysis of the regenerated nerves 16 weeks after surgery from (A) middle cable TC, (B) IOAG, (C) IOAG/GDNF and (D) NC. There is clearly more
positive staining of the myelin sheath-associated protein S-100 (arrows) within the periphery of nerve, indicating well organized structural nerve reconstruction in GDNF treated
nerve compared to that of the IOAG. Scale bar:10 mm.
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wide range of natural and synthetic materials, which may or may
not be resorbable [38]. Surgeons are often not aware of the differ-
ent(bio) materials of these conduits when performing nerve repair
[39].
Because of its inert and elastic properties, the silicon tube was
one of the ﬁrst and most frequently used to bridge the transected
nerves [40]. Nevertheless, these non-biodegradable tubes induce
ﬁbrous capsule formation, leading to chronic nerve compression
and an inﬂammatory response [6]. In order to avoid problems
associated with non-degradable guides, recent research has been
focused on the production of biodegradable nerve guides [41].
These guides provide a good tool to administrate factors which can
improve the regeneration of injured peripheral nerves in human.
However, such a biodegradable guides collapse easily because of
their thin walls [42]. Arteries have been experimentally used as
grafting tubules and promising results have been achieved [11].
The neurotrophin family of neurotrophic factors is a family of
structurally and functionally related peptides which mediate
potent survival and differentiation effects on a wide variety of
neuronal populations in the central and peripheral nervous sys-
tems [12]. Neurotrophins are unique among neurotrophic factors in
their ability to act as guidance molecules for growth cones [43,44].
GDNF, a member of the transforming growth factor-beta family
of growth factor encoding genes, is initially identiﬁed as a survival
factor for midbrain dopaminergic neurons [45]. It has been shown
that it acts on a wide range of neuronal populations in the central
and peripheral nervous system. GDNF has been shown to promote
the survival of developing motoneurons in vivo and in vitro. It can
also promote the survival of adult mouse spinal motoneurons after
injury in vivo [46]. In studying the effects of GDNF on embryonic
motoneuron differentiation neurite outgrowth is promoted in
varying degrees [47]. GDNF exert its effects via a receptor complex
which consists of a high afﬁnity ligand-binding subunit and sub-
sequent coupling to a common signal transduction subunit [48].
Reportedly, synthetic guidance channels continuously releasing
GDNF can support sciatic nerve regeneration across long gaps [49].
Besides functional impairment, nerve injury can also cause debili-
tating neuropathic pain. Neurotrophic factors can also act as pain
modulators [50]. GDNF has been described to have analgesic effects
in animal models of neuropathic pain [51]. Apart from its better
regenerative power, GDNF released by synthetic nerve guidance
channels has been proposed to be an effective treatment for pe-
ripheral nerve repair in the clinic [49].
Even though our preliminary study shows the neuroprotective
action of local GDNF in peripheral nerve injuries, determining the
molecular mechanisms leading to the neuroprotective action re-
mains needs to be investigated. We have not given the histological
and molecular evidence for neuroprotective action of GDNF. Thismay be considered as a limitation to our study. Therefore, the au-
thors stress that the aim of the current investigation was to eval-
uate a single local dose and clinical treatment potential of GDNF on
nerve regeneration including functional assessments of the nerve
repair, a case not considered in previous studies. The results of the
present study indicated that a single local administration of GDNF
at the site of transected nerve could be of beneﬁt after artery graft
tubulization. Detailed mechanism of neuroprotective action re-
mains to be investigated.
In Conclusion results of the present study demonstrated that a
single local application of GDNF could accelerate functional re-
covery after transection of sciatic nerve.
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